Sabizabulin - mCRPC- used now for Covid 19.
posted on
Apr 13, 2022 06:37AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Interesting read,,,,small enrollment and the short period of time for the C19 Plll trial. Share price has sky rocketed up!!!
https://www.onclive.com/view/novel-compound-looks-to-shake-up-mcrpc-treatment-landscape
VERU Inc.
April 11, 2022 06:30 ET | Source: Veru Inc.